Hims

Hims Teams Up with Eli Lilly to Offer Zepbound Through Telehealth Services

2 days ago

In a significant development within the telehealth industry, Hims, a leading healthcare company focused on providing convenient access to prescription medications and wellness products, announced that it will begin selling Eli Lilly’s weight-loss drug, Zepbound, through its online platform. This strategic partnership marks a pivotal moment for both companies as they seek to expand their reach in the weight management market.

Hims Exceeds 2025 Sales Projections Amid Weight Loss Product Concerns

1 month ago

In a surprising announcement, Hims and Hers Health Inc. has revealed its sales outlook for 2025, which exceeds many analysts' expectations despite facing uncertainty surrounding its weight loss product line. This update sent the company's stock soaring as investors reacted positively to the optimistic projections.

Hims Enhances Drug Production with Strategic Acquisition of California Peptide Facility

1 month ago

Hims, a prominent player in the telehealth and pharmaceutical sector, has made a significant move to bolster its drug manufacturing capabilities by acquiring a peptide manufacturing plant in California. This strategic acquisition aligns with the company’s ongoing efforts to expand its product offerings and maintain a competitive edge in the industry.

Hims & Hers Expands Horizons with Strategic Acquisition of At-Home Blood Testing Lab

1 month ago

In a significant move aimed at broadening its healthcare offerings, Hims & Hers, a digital healthcare platform known for its telehealth services, has announced the acquisition of a laboratory specializing in at-home blood testing. This strategic purchase underscores the company's intention to expand its reach into the burgeoning market of convenient, consumer-friendly medical testing solutions.

Insights from Achim Steiner: UN Development Goals in a Changing Climate

2 months ago

Achim Steiner, the Administrator of the United Nations Development Programme (UNDP), recently shared crucial insights on Bloomberg Green’s Zero Podcast. In an engaging conversation, Steiner emphasized the interconnections between development, sustainability, and climate action, underscoring the agency's mission of eradicating poverty and promoting sustainable practices globally.

Hims Faces Historic Decline as Amazon Enters Hair Loss Drug Arena

5 months ago

In a significant market shake-up, Hims & Hers Health Inc. experienced its steepest drop in stock price to date, plummeting by over 30% following the announcement that Amazon is venturing into the hair loss treatment market. This news sent shockwaves through the health and wellness sector, particularly affecting companies that have built their business models around telehealth and direct-to-consumer pharmaceuticals.

Hims Claims New Weight Loss Injection Matches Safety of Ozempic and Wegovy

5 months ago

In a significant advancement in the realm of weight loss medications, Hims & Hers Health Inc. has announced that its new weight loss injection is reportedly just as safe as two of the leading treatments currently available: Ozempic and Wegovy. Both Ozempic and Wegovy have gained fame for their effectiveness in aiding weight loss, primarily through the active ingredient semaglutide, which helps regulate appetite and maintain glucose levels. Hims, a company traditionally recognized for its telehealth services and products related to sexual wellness, is entering the competitive weight-loss market with promising developments.